Can a US-Based strategy improve hodgkin lymphoma outcomes for chinese kids?
NCT ID NCT04726501
First seen Mar 21, 2026 · Last updated Jun 14, 2026 · Updated 17 times
Summary
This study tests whether a treatment plan that works well in the US and Europe can also help Chinese children and teens with newly diagnosed Hodgkin lymphoma. About 200 participants aged 1 to 18 will receive a modified version of the COG (Children's Oncology Group) protocol. The goal is to see if this approach improves event-free survival and overall survival, and to identify challenges in current care in China.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HODGKIN LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nanjing Children's Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
Nanjing, China
-
Shanghai Children's Medical Center
Shanghai, 200127, China
-
West China Second University Hospital, Sichuan University, Chengdu, China
Chengdu, China
Conditions
Explore the condition pages connected to this study.